Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125070) titled 'AI-based multimodal medical information fusion system for decision support in Lung cancer' on May 21.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Cancer Hospital
Condition:
Pulmonary nodules (diameter < 30 mm)
Intervention:
Gold Standard:Histopathological diagnosis is used as the primary gold standard. Malignant pulmonary nodules must be confirmed by pathology, and classified as adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA) or invasive lung cancer according to pathological findings. Benign pulmonary nodules are determined by histopath...